Citadel Advisors »

Aytu Biopharma shares owned by Citadel Advisors

Quarter-by-quarter ownership of Aytu Biopharma (AYTU) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Aytu Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Aytu Biopharma held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aytu Biopharma by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $40k 16k 2.60
2025-03-31 $37k 31k 1.20
2024-12-31 $19k 11k 1.67
2024-06-30 $64k 22k 2.91
2024-03-31 $37k 12k 3.04

More positions owned by Citadel Advisors

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Tesla Motors Call Option (TSLA)
NVIDIA Corporation Call Option (NVDA)
Apple Call Option (AAPL)
Meta Platforms Cl A Call Option (META)
Amazon Call Option (AMZN)
Spdr Gold Tr Gold Shs Call Option (GLD)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Microsoft Corporation Call Option (MSFT)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Broadcom Call Option (AVGO)
Netflix Call Option (NFLX)
Alphabet Cap Stk Cl C Call Option (GOOG)
Advanced Micro Devices Call Option (AMD)

View all positions for Citadel Advisors

Top funds holding Aytu Biopharma

Nantahala Capital Management
Stonepine Capital Management
AWM Investment Company
Diadema Partners
Vanguard Group
Two Sigma Investments
Renaissance Technologies
Persistent Asset Partners
Geode Capital Management
Two Sigma Advisers
Dimensional Fund Advisors
DRW Holdings
XTX Topco
Bellevue Asset Management
BlackRock

View all funds holding Aytu Biopharma